A Phase II Randomized Study of Lenalidomide or Lenalidomide and Rituximab as Maintenance Therapy Following Standard Chemotherapy for Patients with High/High-intermediate risk Diffuse Large B-Cell Lymphoma

Detalles Bibliográficos
Autores principales: Reddy, Nishitha M., Greer, John P., Morgan, David S., Chen, Heidi, Park, Steven I., Richards, Kristy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214342/
https://www.ncbi.nlm.nih.gov/pubmed/27654851
http://dx.doi.org/10.1038/leu.2016.255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214342/
https://www.ncbi.nlm.nih.gov/pubmed/27654851
http://dx.doi.org/10.1038/leu.2016.255

Ejemplares similares